Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,809,940
+$409,131 QoQ
Shares Held
1,509
-0.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
#2,580
of 4,605 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Calydon Capital holds $35,751,780 across 10 Drug Manufacturers - General names. LLY ranks #5 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
36,979 | $9,391,556 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
58,233 | $7,357,157 | |
| 3 | AMGN |
Amgen Inc
|
20,308 | $7,353,932 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
123,497 | $7,115,897 | |
| 5 | LLY |
ELI LILLY & Co
This page
|
1,509 | $1,809,940 | |
| 6 | AZN |
Astrazeneca PLC
|
4,923 | $933,499 | |
| 7 | NVS |
Novartis AG
|
5,755 | $901,923 | |
| 8 | MRK |
Merck & Co., Inc.
|
2,772 | $356,202 |
All Filings in LLY
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,809,940 | 1,509 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,400,809 | 1,523 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,695,845 | 1,578 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,915,130 | 2,510 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,129,170 | 5,297 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,882,248 | 2,279 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,666,748 | 2,159 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $3,176,094 | 3,585 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,064,266 | 2,280 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,796,309 | 2,309 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,513,843 | 2,597 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $1,505,038 | 2,802 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $1,393,339 | 2,971 | Shares | Sole | 2023-08-21 | |
| 2023-03-31 | $1,031,977 | 3,005 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,409,581 | 3,853 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $1,287,256 | 3,981 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,198,029 | 3,695 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,148,343 | 4,010 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $1,059,856 | 3,837 | Shares | Sole | 2022-02-07 | |
| No filing history on record for this holder in this stock. | ||||||